“Men At Risk: The Dirty Little Secret” Set for Worldwide Release in Atlanta
ATLANTA--(BUSINESS WIRE)-- Practicing urologist and prostate cancer specialist Dr. Ronald Wheeler, MD says he plans to share the secret about which the urology community is keeping tightlipped: Prostate Biopsies Really Do Spread Prostate Cancer Cells. A press conference is planned during American Urological Association’s national meeting, which is expected to draw an estimated 15-thousand physician, health care professionals and exhibitors to Georgia World Congress Center in Atlanta from May 19th to May 23rd, 2012.
“Because of poor judgment and a lack of sufficient knowledge by practicing urologists, many men are over-treated; many men mistreated while all suffer from a so-called innocuous prostate biopsy,” said Dr. Wheeler, who has been a practicing urologist for more than 25 years. “The book is extremely controversial, I have written it intentionally to change the culture in urology as related to the diagnosis and treatment of prostate cancer for the health and wellness of patients.”
Dr. Ronald Wheeler says an evaluation with Magnetic Resonance Imaging (MRI) will become the most dominant diagnostic test for prostate cancer in the not too distant future. “Women go through routine mammograms for cancer screening. It is mind boggling to think men are subjected to harmful biopsies performed randomly with a risk of spreading cancer cells.”
Dr. Wheeler, who is the Medical Director at Diagnostic Center for Disease based in Sarasota, Fl, has planned a book tour across major cities in the U.S. called “Men at Risk: The Dirty Little Secret: Biopsies Really Do Spread Prostate Cancer cells” to educate patients, and their loved ones. The book also addresses not so talked about Andropause, similar to women’s menopause.
*Quality of life including sexual function and urinary continence is guaranteed with HIFU (High Intensity Focused Ultrasound)
*Treat conservatively wherever possible; 30 – 56% of all prostate cancers are over treated with radical surgery or radiation (Reference: Michael Barry, MD Harvard)
*50-60% of patients diagnosed with prostate cancer can live with prostate cancer using a CDM (Chronic Disease Management) approach
*A negative biopsy with a rising PSA can only represent a “missed cancer”
*40-60% of men who have Radical Prostatectomy or Radiation fail to be cured by 7-10years (Reference: JAMA, Journal of Urology)
*3.0 Tesla Magnetic Resonance Imaging scanning diagnoses prostate cancer without a biopsy
The problem is that, in nearly all cases, the biopsy is essentially done blindly, according to an article in Radiology Today. http://www.fortherecordmag.com/archives/033009p24.shtml An estimated one million prostate biopsies are done annually. Studies show these biopsies miss about 20% of all malignancies and generally underestimate the disease. Researchers reportedly began looking at MRI as a way of improving the early diagnosis of prostate cancer, just as MRI has increased early breast cancer detection in women who are at very high risk and/or who have very dense breasts.
African-American men may have the highest rate of prostate cancer incidence in the world, and the reasons are unclear. In addition, their prostate cancer mortality rate is more than twice as high as the rate for white Americans. According to one study, in the period from 2003 to 2007, mortality rates were 22.8 cases per 100,000 white men, and 54.2 cases per 100,000 African-American men.
Accurate results are critical, as they determine how the patient is treated, according to an assistant professor of radiology at the UCLA David Geffen School of Medicine. “The physicians will decide whether it is best the patient be watched or go to surgery, radiation therapy, or hormonal therapy.”
“Prostate cancer is the most dominant disease of men. And equally misunderstood!” says Dr. Wheeler. An estimated half-million men per year will be diagnosed with prostate cancer in the US alone.
The book “Men at Risk: The Dirty Little Secret” can be purchased online: MenAtRisk.net. Dr. Ronald Wheeler, who is the Medical Director of Diagnostic Center for Disease, is available for speaking engagements. [email protected] or (703) 371-2007.
CONTACT:
Media Inquiries:
TriPath Media
Patti Tripathi, 703-371-2007
[email protected]
KEYWORDS: United States North America Georgia
INDUSTRY KEYWORDS: Entertainment Surgery Health Hospitals Oncology Books Consumer Men
MEDIA: